CRISPR prime editing for unconstrained correction of oncogenic KRAS variants https://www.biorxiv.org/content/10.1101/2022.12.21.521522v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.